Video
Developing an active surveillance protocol for patients receiving a diagnosis of prostate cancer after HoLEP
Author(s):
Ashley E. Ross, MD, PhD, provides an overview of his institution’s new protocol for this subset of patients.
Video Player is loading.
In this video, Ashley E. Ross, MD, PhD, discusses an active surveillance protocol for patients undergoing holmium laser enucleation of the prostate for benign prostatic hyperplasia who subsequently receive a diagnosis of prostate cancer. Ross is an associate professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Related Videos
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
Study results affirm effectiveness of evolving prostate cancer therapies
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Comparing Trials Studying Treatment Intensification In mHSPC
Related Content
